Literature DB >> 4609530

The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat.

J R Parratt, R M Sturgess.   

Abstract

1 The response of pentobarbitone-anaesthetized cats to the intravenous administration of E. coli endotoxin (2 mg/kg) consisted of acute pulmonary vasoconstriction (3-5 min after the injection) and a secondary shock phase characterized by delayed systemic hypotension, decreased central venous pressure and cardiac output, and metabolic acidosis with arterial lactate levels three to four times normal. Only one of 25 animals survived 6 hours.2 Indomethacin (10 mg/kg), administered intravenously 30 min before the endotoxin, reduced both systemic arterial pressure and myocardial blood flow. It abolished the pulmonary vasoconstriction induced by endotoxin.3 Indomethacin modified some of the characteristic features of the delayed, endotoxin shock phase. Systemic hypotension was not observed and the blood pressure in the indomethacintreated cats 1, 2 and 4 h after endotoxin was 30 mmHg higher than in those cats administered endotoxin alone. The decrease in arterial pH was also significantly delayed. Six out of 15 animals survived 6 hours.4 It is suggested that indomethacin may abolish the initial pulmonary hypertension and oedema by antagonizing the release, or vasoconstrictor effect, of histamine and that part of its action during the shock phase is due to inhibition of prostaglandin release.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4609530      PMCID: PMC1776639          DOI: 10.1111/j.1476-5381.1974.tb08559.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Effect of indomethacin in endotoxin shock in the dog.

Authors:  E G Erdös; L B Hinshaw; C C Gill
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

2.  Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs.

Authors:  B J NORTHOVER; G SUBRAMANIAN
Journal:  J Pathol Bacteriol       Date:  1962-04

3.  Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

4.  Effects of anti-inflammatory drugs in shock caused by injection of living E. coli cells.

Authors:  J R Culp; E G Erdös; I B Hinshaw; D D Holmes
Journal:  Proc Soc Exp Biol Med       Date:  1971-05

5.  Evidence for the presence of prostaglandin-like material in the plasma of dogs with endotoxin shock.

Authors:  E Kessler; R C Hughes; E N Bennett; S M Nadela
Journal:  J Lab Clin Med       Date:  1973-01

6.  Aspirin and pulmonary lesions in endotoxin shock.

Authors:  V S Murphy; C V Greenway
Journal:  Am Heart J       Date:  1972-10       Impact factor: 4.749

7.  Effect of acetylsalicylic acid on the liver response to endotoxin.

Authors:  L A Solomon; L B Hinshaw
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

8.  Indomethacin and aspirin abolish prostaglandin release from the spleen.

Authors:  S H Ferreira; S Moncada; J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

9.  The role of intravascular coagulation in feline endotoxin shock.

Authors:  W E Lucas; J L Kitzmiller
Journal:  Surg Gynecol Obstet       Date:  1972-01

10.  Blood gas calculator.

Authors:  J W Severinghaus
Journal:  J Appl Physiol       Date:  1966-05       Impact factor: 3.531

View more
  17 in total

1.  The protective effect of sodium meclofenamate in experimental endotoxin shock.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  E. coli endotoxin shock in the cat; treatment with indomethacin.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

3.  Prostaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.

Authors:  J R Parratt; N Sharma; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

4.  Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Authors:  C Szabó; J A Mitchell; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

5.  Release of prostaglandin-like substances by Shigella endotoxin and its inhibition by non-steroidal anti-inflammatory compounds.

Authors:  P Bhattacherjee
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

6.  The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

7.  Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.

Authors:  T Mózes; F J Zijlstra; J P Heiligers; C J Tak; S Ben-Efraim; I L Bonta; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

8.  Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.

Authors:  R Winn; J Harlan; B Nadir; L Harker; J Hildebrandt
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin.

Authors:  J R Fletcher; P W Ramwell
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

10.  Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog.

Authors:  J R Fletcher; P W Ramwell
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.